A Study of SGB-9768 in Patients with Complement-mediated Kidney Diseases
Clinical trial NCT06786338 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06786338
- Sponsor
- Suzhou Sanegene Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2026-07-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.